NTRK2 and depressive disorder: Multiple preclinical and clinical studies have implicated impaired BDNF signaling through its receptor TrkB in the pathogenesis of depression, while increased expression and signaling of BDNF has been implicated in antidepressant-related events, and plasticity has increasingly been connected with antidepressant action [59].